←
CheckRare14,543 posts
CheckRare avatar

CheckRare

@CheckRare

Leading publisher and learning platform focused on rare diseases. Rare Diseases Are Our Focus, Expertise, and Passion.

◷ Joined December 2016▧ 1,709 Photos and videos
CheckRare avatar
CheckRare@CheckRare·Oct 1

October is Rett Syndrome Awareness Month 💜 Rett syndrome is a neurodevelopmental condition characterized by normal psychomotor development during the first 6 to 18 months of life, followed by the development of severe problems with language and communication, learning, coordination, and other brain functions. This month, join us in recognizing the importance of continued research, multidisciplinary care, patient advocacy, and education. Learn more at checkrare.com/rett-syndrome-… #RettSyndromeAwarenessMonth #RettSyndrome #Rett #RareDisease

Post attachment
CheckRare avatar
CheckRare@CheckRare·2h

Access to essential rare disease therapies remains a critical concern for patients and healthcare providers. In this special edition of The CheckRare Brief, we speak with @sanofi leadership about ongoing manufacturing and supply challenges affecting several rare disease treatments, including therapies for Pompe, Fabry, Gaucher, and ASMD. Learn more about the anticipated supply disruptions, their potential impact on patients, and what Sanofi is doing to address these challenges and prevent future disruptions. Watch the full discussion at checkrare.com/sanofis-orphan… #RareDisease #DrugSupply #PatientAccess #PompeDisease #FabryDisease #GaucherDisease #ASMD #Sanofi

Post attachment
CheckRare avatar
CheckRare@CheckRare·Nov 13

New research is helping advance the understanding and treatment of rare kidney diseases. The VALIANT study evaluated pegcetacoplan, a targeted complement therapy, in patients with C3G and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN). Explore the study and hear more about the importance of advancing treatment options for patients, including children. Read the full story: checkrare.com/c3g-and-the-pe…

Post attachment
CheckRare avatar
CheckRare@CheckRare·Nov 12

What should you know about myasthenia gravis? From understanding the underlying disease mechanisms to exploring FDA-approved treatment options and ongoing clinical research, staying informed is essential for the rare disease community. The Myasthenia Gravis Disease Learning Center brings together educational information and resources to help patients, caregivers, and healthcare professionals better understand this complex condition. Explore the learning center: checkrare.com/myasthenia-gra… #MyastheniaGravis #RareDiseaseEducation #HealthcareProfessionals #ClinicalResearch #PatientEducation

Post attachment
CheckRare avatar
CheckRare@CheckRare·Nov 10

Johan Maertens, MD, PhD, Professor of Hematology at University Hospitals Leuven (UZ Leuven) in Belgium and Principal Investigator of the OASIS study, discusses positive phase 3 trial results evaluating oral olorofim in patients with invasive aspergillosis. View the full interview at checkrare.com/phase-3-oasis-…

0:57
CheckRare avatar
CheckRare@CheckRare·Nov 10

🧬 A new chapter in gene therapy for spinal muscular atrophy (SMA). How is Itvisma changing the treatment landscape for people living with SMA? In this CheckRare feature, John Day, MD, PhD, of Stanford University, discusses the development of this one-time gene therapy, its targeted delivery approach, and clinical trial findings on motor function. Discover what this advancement could mean for the future of SMA treatment. 🔗 Read the full article: checkrare.com/itvisma-gene-t… #CheckRare #SpinalMuscularAtrophy #SMA #RareDisease #GeneTherapy #MedicalInnovation

Post attachment
CheckRare avatar
CheckRare@CheckRare·Nov 4

The National Organization for Rare Disorders (NORD) is hosting a free "Living Rare, Living Stronger" event in South Florida on Dec. 4, for rare disease patients, families, caregivers, and health care advocates. Connect with others on similar journeys and learn about locally available resources and opportunities. Register here: livingrare.org/florida/

Post attachment
CheckRare avatar
CheckRare@CheckRare·Oct 30

From C5-targeted therapies to myasthenic crisis management, AANEM 2026 brought forward important discussions on the evolving treatment landscape for generalized myasthenia gravis (gMG). Explore the highlights with CheckRare: checkrare.com/generalized-my…

Post attachment
CheckRare avatar
CheckRare@CheckRare·Oct 30

Episode 3 of Rare Endocrine Exchange is out now! Hosted by Margarita Ochoa-Maya, MD, and with guest Katherine Arakay, MD, we discuss clinical trials for rare endocrine disorders, examined from three perspectives: patients, clinical researchers, and sponsors. Listen now at checkrare.com/clinical-trial…

Post attachment